FDA inspection
DaVita Clinical Research: FDA inspection ending Apr 7, 2000
FDA inspection 19261 · Voluntary Action Indicated (VAI) · Minneapolis, MN
Key facts
| Inspection ID | 19261 |
|---|---|
| Firm | DaVita Clinical Research |
| FEI number | 3002980831 |
| Address | 825 S 8th St, Suite 300 |
| City | Minneapolis |
| State | MN |
| ZIP | 55404-1211 |
| Fiscal year | 2000 |
| Inspection end date | Apr 7, 2000 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Human Cellular, Tissue and Gene Therapies |
| Product type | Biologics, Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data